|
Volumn 356, Issue 6338, 2017, Pages 586-587
|
Myriad take two: Can genomic databases remain secret?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADVANCED TECHNOLOGY;
DATA MANAGEMENT;
DATABASE;
GENOMICS;
HEALTH SERVICES;
HEALTH STATUS;
INDUSTRIAL ENTERPRISE;
INTELLECTUAL PROPERTY RIGHTS;
LEGAL SYSTEM;
POLICY MAKING;
PUBLIC HEALTH;
SCIENCE AND TECHNOLOGY;
TECHNOLOGICAL DEVELOPMENT;
TECHNOLOGY POLICY;
ACCESS TO INFORMATION;
COMPUTER SECURITY;
CONFIDENTIALITY;
FACTUAL DATABASE;
GENOMIC DATABASE;
GOVERNMENT;
HUMAN;
IDENTIFIABLE INFORMATION;
LAW;
MEDICAL INFORMATION;
PRIORITY JOURNAL;
SHORT SURVEY;
ALGORITHM;
BREAST TUMOR;
FEMALE;
GENETIC DATABASE;
GENETIC PRIVACY;
GENETICS;
HEALTH INSURANCE;
LEGISLATION AND JURISPRUDENCE;
OVARY TUMOR;
PATENT;
TUMOR SUPPRESSOR GENE;
UNITED STATES;
ALGORITHMS;
BREAST NEOPLASMS;
DATABASES, GENETIC;
FEMALE;
GENES, BRCA1;
GENES, BRCA2;
GENETIC PRIVACY;
HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT;
HUMANS;
OVARIAN NEOPLASMS;
PATENTS AS TOPIC;
UNITED STATES;
|
EID: 85019243450
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.aal3224 Document Type: Short Survey |
Times cited : (12)
|
References (16)
|